Acutaas Chemicals logo

Acutaas Chemicals MD, chairman, board of directors and AGM

NSE: ACUTAASBSE: 543349Pharmaceuticals & BiotechnologySmall Cap

Formerly Ami Organics
Last close ₹3,137.70down ₹77.60 (2.41%)BSE ₹3,138.55

Share price at the NSE close on 23 Oct 2026. Previous close ₹3,215.30.

52-week range of traded prices to 23 Oct 2026
₹1,570.00Low, 21 Jan 2026₹3,740.00High, 6 Jul 2026
Market cap
₹25,689 Cr347th largest listed
P/E
66.5
P/B
15.5
Dividend yield
0.08%
ROE
26.1%
ROCE
29.1%
Debt to equity
0.02
Volume, NSE
3,48,10955.1% delivered

Acutaas Chemicals board of directors

At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

  • Chairperson and managing directorNARESHKUMAR RAMJIBHAI PATELRelated to the promoter
  • Company Secretary and Compliance OfficerEKTA KUMARI SRIVASTAVA

8 directors4 independent4 executive

  • NARESHKUMAR RAMJIBHAI PATEL · Chairperson and managing directorExecutive · joined Jun 2007 · reappointed May 2026 · 1 listed board · 1 committee seat
  • CHETANKUMAR CHHAGANLAL VAGHASIAExecutive · joined Jun 2007 · reappointed May 2026 · 1 listed board · 1 committee seat
  • VIRENDRA NATH MISHRAExecutive · joined Mar 2021 · reappointed Apr 2026 · 1 listed board
  • RAM MOHAN LOKHANDEExecutive · joined Feb 2022 · reappointed Feb 2022 · 1 listed board
  • HETAL MADHUKANT GANDHIIndependent · joined Apr 2021 · reappointed Apr 2026 · 62 months as independent · 6 listed boards · 5 as independent · 5 committee seats, 2 as chair
  • GIRIKRISHNA MANIARIndependent · joined Apr 2018 · reappointed Apr 2023 · 98 months as independent · 1 listed board · 1 as independent · 1 committee seat, 1 as chair
  • RICHA MANOJ GOYALIndependent · joined Apr 2021 · reappointed Apr 2026 · 63 months as independent · 6 listed boards · 6 as independent · 8 committee seats, 4 as chair
  • ANITA BANDYOPADHYAYIndependent · joined Feb 2022 · reappointed Feb 2022 · 53 months as independent · 3 listed boards · 3 as independent · 2 committee seats, 1 as chair

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

  • Board

    • 30 Apr 20268 of 8 present4 independent · 91 days in between
    • 28 Jan 20268 of 8 present4 independent
  • Audit Committee

    Chair GIRIKRISHNA MANIAR

    HETAL MADHUKANT GANDHI, RICHA MANOJ GOYAL

    • 30 Apr 20263 of 3 present3 independent · 40 days in between
    • 20 Mar 20263 of 3 present3 independent
  • Nomination and remuneration committee

    Chair HETAL MADHUKANT GANDHI

    GIRIKRISHNA MANIAR, ANITA BANDYOPADHYAY

    • 30 Apr 20263 of 3 present3 independent
  • Stakeholders Relationship Committee

    Chair RICHA MANOJ GOYAL

    NARESHKUMAR RAMJIBHAI PATEL, CHETANKUMAR CHHAGANLAL VAGHASIA

    No meeting listed in the filing.

  • Risk Management Committee

    Chair NARESHKUMAR RAMJIBHAI PATEL

    CHETANKUMAR CHHAGANLAL VAGHASIA, RICHA MANOJ GOYAL, BHAVIN N. SHAH

    • 11 Jun 20263 of 3 present1 independent · 137 days in between
    • 24 Jan 20263 of 3 present1 independent
  • Corporate Social Responsibility Committee

    Chair RICHA MANOJ GOYAL

    NARESHKUMAR RAMJIBHAI PATEL, CHETANKUMAR CHHAGANLAL VAGHASIA

    • 11 Jun 20263 of 3 present1 independent · 53 days in between
    • 18 Apr 20263 of 3 present1 independent

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Mar 2026.

  • Maheshwari & Co.Peer-review certificate valid to Feb 2029
1 earlier auditor
  • M/s. Maheshwari & Co.Named in the filing for the quarter to Mar 2025

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Acutaas Chemicals AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Acutaas Chemicals dividend history

Annual general meeting, 24 Sep 2026

1,45,546 shareholders on the register on 17 Sep 2026; present: 2 promoters and 84 others; votes counted by Kashyap Shah / M/s. Kashyap Shah & Co..The company's voting result (opens in a new tab)

  1. Adoption of the Audited Financial Statements of the Company together with the schedules and notes attached thereto for the financial year ended on 31st March, 2026 along with the reports of the Board of Directors and Auditors thereonMoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 74.63% · promoters 100.00% · institutions 83.60% · other public 26.50%

  2. Declaration of Final Dividend for the financial year 2025-26
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 74.84% · promoters 100.00% · institutions 84.10% · other public 26.50%

  3. Re-appointment of Mr. Chetankumar C. Vaghasia (DIN : 01375540), who retires by rotation and being eligible, offers himself for re-appointment
    OrdinaryPromoters have an interest in it
    97.48% for2.52% against

    Against: promoters 0.00% · institutions 5.30% · other public 0.00%

    Turnout: all 74.82% · promoters 100.00% · institutions 84.05% · other public 26.50%

  4. Ratification of remuneration of Cost Auditors for financial year 2026-27
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 74.82% · promoters 100.00% · institutions 84.05% · other public 26.50%

  5. Reappointment of Mr. Ram Mohan Lokhande (DIN 08117035), as the Whole Time Director of Company and approval of payment of remuneration
    Ordinary
    99.88% for0.12% against

    Against: promoters 0.00% · institutions 0.25% · other public 0.00%

    Turnout: all 74.82% · promoters 100.00% · institutions 84.05% · other public 26.50%

  6. Re-appointment of Mrs. Anita Bandyopadhyay (DIN: 08672071), as Director (Non-Executive & Independent) of the company for second term of five consecutive years
    Special
    97.78% for2.22% against

    Against: promoters 0.00% · institutions 4.68% · other public 0.00%

    Turnout: all 74.82% · promoters 100.00% · institutions 84.05% · other public 26.50%

  7. To Grant employee stock options to the employees of subsidiary company(ies) under ‘Ami Organics Employees Stock Option Scheme 2023
    SpecialNot passedRecorded as not passed although most votes were for it; no reason is given
    72.63% for27.37% against

    Against: promoters 0.00% · institutions 57.67% · other public 0.00%

    Turnout: all 74.82% · promoters 100.00% · institutions 84.05% · other public 26.50%

  8. Approval to advance Loan or give Guarantee or provide Security under section 185 of the Companies Act, 2013
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 74.82% · promoters 100.00% · institutions 84.05% · other public 26.50%

  9. Approval of Material Related Party Transactions with the subsidiary company- Acutaas Chemicals Electrolytes Private Limited
    OrdinaryPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 41.40% · promoters 0.00% · institutions 84.05% · other public 23.45%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 25 Sep 2025, 11 resolutions

1,15,883 shareholders on the register on 18 Sep 2025; present: 2 promoters and 72 others; votes counted by KASHYAP SHAH / M/S. KASHYAP SHAH & CO..The company's voting result (opens in a new tab)

  1. Adoption of the Audited Financial Statements of the Company together with the schedules and notes attached thereto for the financial year ended on 31st March, 2025 along with the reports of the Board of Directors and Auditors thereonMoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 69.26% · promoters 100.00% · institutions 73.83% · other public 26.93%

  2. Declaration of Final Dividend for the financial year 2024-2
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 69.32% · promoters 100.00% · institutions 73.95% · other public 26.93%

  3. Re-appointment of Mr. Nareshkumar Ramjibhai Patel (DIN : 00906232), who retires by rotation and being eligible, offers himself for re-appointment
    OrdinaryPromoters have an interest in it
    98.29% for1.71% against

    Against: promoters 0.00% · institutions 4.07% · other public 0.00%

    Turnout: all 69.28% · promoters 100.00% · institutions 73.88% · other public 26.93%

  4. Ratification of remuneration of Cost Auditors for financial year 2025-26
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 69.32% · promoters 100.00% · institutions 73.95% · other public 26.93%

  5. Reappointment of Mr. Nareshkumar Ramjibhai Patel (DIN 00906232), as the Managing Director, designated as Executive Chairman & Managing Director and approval of payment of remuneration
    SpecialPromoters have an interest in it
    82.18% for17.82% against

    Against: promoters 0.00% · institutions 42.41% · other public 0.00%

    Turnout: all 69.32% · promoters 100.00% · institutions 73.95% · other public 26.93%

  6. Reappointment of Mr. Chetankumar Chhaganlal Vaghasia (DIN 01375540), as the Whole Time Director of Company and approval of payment of remuneration
    SpecialPromoters have an interest in it
    82.18% for17.82% against

    Against: promoters 0.00% · institutions 42.41% · other public 0.00%

    Turnout: all 69.32% · promoters 100.00% · institutions 73.95% · other public 26.93%

  7. Reappointment of Mr. Virendra Nath Mishra (DIN 07815490), as the Whole Time Director of Company and approval of payment of remuneration
    Special
    92.39% for7.61% against

    Against: promoters 0.00% · institutions 18.13% · other public 0.00%

    Turnout: all 69.29% · promoters 100.00% · institutions 73.89% · other public 26.93%

  8. Re-appointment of Mrs. Richa Manoj Goyal (DIN 00159889), as Director (Non-Executive & Independent) of the company for second term of five years
    Special
    99.33% for0.67% against

    Against: promoters 0.00% · institutions 1.59% · other public 0.00%

    Turnout: all 69.32% · promoters 100.00% · institutions 73.95% · other public 26.93%

  9. Re-appointment of Mr. Hetal Madhukant Gandhi (DIN 00106895), as Director (Non-Executive & Independent) of the company for second term of five years
    Special
    95.29% for4.71% against

    Against: promoters 0.00% · institutions 11.21% · other public 0.00%

    Turnout: all 69.32% · promoters 100.00% · institutions 73.95% · other public 26.93%

  10. Approval for payment of commission to Non - Executive Directors of the Company
    Ordinary
    81.97% for18.03% against

    Against: promoters 0.00% · institutions 42.90% · other public 0.00%

    Turnout: all 69.32% · promoters 100.00% · institutions 73.95% · other public 26.93%

  11. Appointment of M/s KSPS & Co. LLP as the Secretarial Auditors of Company
    Ordinary
    99.31% for0.69% against

    Against: promoters 0.00% · institutions 1.65% · other public 0.00%

    Turnout: all 69.32% · promoters 100.00% · institutions 73.95% · other public 26.93%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

How mutual funds voted

Fund houses must disclose how they vote at every meeting of a company they hold.Funds that hold it

Mutual fund votes, meeting of 24 Sep 2026, 13 fund houses so far (houses' deadline to file 15 Oct 2026)

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • Adoption of the Audited Financial Statements of the Company together with the schedules and notes attached thereto for the financial year ended on 31st March, 2026 along with the reports of the Board of Directors and Auditors thereonMoreLess
    13 for0 against
  • Declaration of Final Dividend for the financial year 2025-26
    13 for0 against
  • Re-appointment of Mr. Chetankumar C. Vaghasia (DIN : 01375540), who retires by rotation and being eligible, offers himself for re-appointment
    Against Angel One Mutual Fund, Edelweiss Mutual Fund, Navi Mutual Fund, PGIM India Mutual Fund
    • Angel One Mutual FundGovernance Concern: The remuneration practice of the Company among Executive Directors appears to be skewed in favour of promoter Executive Directors and unfairly biased against the Professional Executive Director, viz. Mr. Virendranath Mishra and no adequate justification has been provided regarding such disproportionate remuneration.
    • Edelweiss Mutual Fund, Navi Mutual Fund, PGIM India Mutual FundNo concern on the merits of proposed appointee. Governance Concern: The remuneration practice of the Company among EDs appears to be skewed in favour of promoter EDs and unfairly biased against the Professional ED, viz. Mr. Virendranath Mishra and no adequate justification has been provided regarding such disproportionate remuneration.
    9 for4 against
  • Ratification of remuneration of Cost Auditors for financial year 2026-27
    13 for0 against
  • Reappointment of Mr. Ram Mohan Lokhande (DIN 08117035), as the Whole Time Director of Company and approval of payment of remuneration
    13 for0 against
  • Re-appointment of Mrs. Anita Bandyopadhyay (DIN: 08672071), as Director (Non-Executive & Independent) of the company for second term of five consecutive years
    Against Angel One Mutual Fund, Edelweiss Mutual Fund, Navi Mutual Fund, PGIM India Mutual Fund
    • Angel One Mutual FundGovernance Concern: The remuneration practice of the Company among Executive Directors appears to be skewed in favour of promoter Executive Directors and unfairly biased against the Professional Executive Director, viz. Mr. Virendranath Mishra and no adequate justification has been provided regarding such disproportionate remuneration. The proposed director is a member of Nomination and remuneration committee, hence should be held accountable for unfair remuneration practices among the Executive Directors.
    • Edelweiss Mutual Fund, Navi Mutual Fund, PGIM India Mutual FundCompliant with law. No governance concern identified with regard to profile, time commitment, attendance and independence of the proposed appointee. Governance Concern: The remuneration practice of the Company among EDs appears to be skewed in favour of promoter EDs and unfairly biased against the Professional ED, viz. Mr. Virendranath Mishra and no adequate justification has been provided regarding such disproportionate remuneration. The proposed director is a member of Nomination and remuneration committee, hence should be held accountable for unfair remuneration practices among the EDs.
    9 for4 against
  • To Grant employee stock options to the employees of subsidiary company(ies) under ‘Ami Organics Employees Stock Option Scheme 2023
    Against Angel One Mutual Fund, DSP Mutual Fund, Edelweiss Mutual Fund, ICICI Prudential Mutual Fund, Jio BlackRock Mutual Fund, Navi Mutual Fund, PGIM India Mutual Fund, SBI Mutual Fund, Tata Mutual Fund
    • Angel One Mutual FundThe Nomination and remuneration committee has been given the absolute discretion to determine the Exercise Price under ESOS 2023. Governance Concern: Exercise Period in case of ‘Termination other than misconduct’ does not appear to be aligned with the objective of granting ESOPs and may not in the favour of employee interest.
    • DSP Mutual Fund, Jio BlackRock Mutual FundThe Ami Organics Employees Stock Option Scheme 2023 was approved by shareholders at the 2023 Postal Ballot. Under the scheme, options exercisable up to 364,370 equity shares – post share split (record date 1 April 2025) 6,68,740 options will be issued to employees of the company. The exercise price will not be lower than the face value of Rs. 10.0 and not higher than the IPO Price of Rs. 610.0 per share. However, post share split, exercise price per option shall not be less than the Rs. 5.0 face value and shall not exceed Rs. 305.0 per share. We do not favour ESOP schemes where options are granted at a significant discount (of more than 20%) to the market price. ESOPs are ‘pay at risk’ options that employees accept at the time of grant, which is protected if the ESOPs are issued at significant discount to the market price. Additionally, we note that certain percentage of options under the scheme be performance based . We do not favour stock option schemes where there is no clarity on the performance metrics for vesting. We do not support the resolution.
    • Edelweiss Mutual Fund, Navi Mutual FundNo concern identified with regard to extension of benefits to employees of subsidiary companies per se. Employees Stock Option Scheme 2023 (ESOS 2023) of the Company is per se Non-Compliant with Schedule I, Part C of SEBI SBEB & SE Regulations, 2021: The NRC has been given the absolute discretion to determine the Exercise Price under ESOS 2023. Governance Concern: Exercise Period in case of ‘Termination other than misconduct’ does not appear to be aligned with the objective of granting ESOPs and may not in the favour of employee interest.
    • ICICI Prudential Mutual FundThe AMC has voted against the resolution due to the inadequate disclosure. (Exercise price not disclosed under ESOS 2023)
    • PGIM India Mutual FundNo concern identified with regard to extension of benefits to employees of subsidiary companies per se. Employees Stock Option Scheme 2023 (ESOS 2023) of the Company is per se Non-Compliant with Schedule I, Part C of SEBI SBEB & SE Regulations, 2021: The NRC has been given the absolute discretion to determine the Exercise Price under ESOS 2023. Governance Concern: Exercise Period in case of Termination other than misconduct does not appear to be aligned with the objective of granting ESOPs and may not in the favour of employee interest.
    • SBI Mutual FundThe Ami Organics Employees Stock Option Scheme 2023 was approved by shareholders at the 2023 Postal Ballot. Under the scheme, options exercisable up to 364,370 equity shares – post share split (record date 1 April 2025) 6,68,740 options will be issued to employees of the company. The exercise price will not be lower than the face value of Rs. 10.0 and not higher than the IPO Price of Rs. 610.0 per share. However, post share split, exercise price per option shall not be less than the Rs. 5.0 face value and shall not exceed Rs. 305.0 per share. We do not support the resolution.
    • Tata Mutual FundNo disclosure on ESOP grant price. Range given as "not less than face value and not more than IPO price". We do not support ESOPS granted at face value nor do we support deeply discounted ESOPs as in this case even on the upper price band (at IPO price implied discount comes out to approx 90%). Thus we do not support the resolution.
    4 for9 against
  • Approval of Material Related Party Transactions with the subsidiary company- Acutaas Chemicals Electrolytes Private Limited
    12 for0 against
4 proposals not matched to one resolution
  • 8) Approve grant of loan/guarantee/provision of security upto Rs. 1,000.0 mn under Section 185 to Acutaas Chemicals Electrolytes Private Limited
    1 for0 against
  • Approval of Material Related Party Transactions with the subsidiary company Acutaas Chemicals Electrolytes Private Limited, the aggregate value of the Related Party Transactions with ACEPL shall not breach the maximum limit of Rs. 2,900 million, from the date of the 19th Annual General Meeting up to the date of the 20th Annual General Meeting (both days inclusive), provided that the said contract(s)/arrangement(s) /agreement(s)/transaction(s), shall be carried out in the ordinary course of business of the Company and at an arm’s length basis.MoreLess
    1 for0 against
  • Approve grant of loan/guarantee/provision of security upto Rs. 1,000.0 mn under Section 185 to Acutaas Chemicals Electrolytes Private Limited
    2 for0 against
  • To advance, from time to time, loan(s) in one or more tranches including loan represented by way of book debt (Loan) , and/or giving of guarantee(s), and/ or providing of security(ies) in connection with any Loan taken/ to be taken by Acutaas Chemicals Electrolytes Private Limited (ACEPL) a Subsidiary of the Company, up to a sum not exceeding Rs. 1000/- million outstanding at any point of time as may be decided by the Board in its absolute discretion, deem beneficial and in the best interest of the Company.MoreLess
    10 for0 against

Mutual fund votes, meeting of 25 Sep 2025, 20 fund houses

  • Adoption of the Audited Financial Statements of the Company together with the schedules and notes attached thereto for the financial year ended on 31st March, 2025 along with the reports of the Board of Directors and Auditors thereonMoreLess
    20 for0 against
  • Declaration of Final Dividend for the financial year 2024-2
    20 for0 against
  • Re-appointment of Mr. Nareshkumar Ramjibhai Patel (DIN : 00906232), who retires by rotation and being eligible, offers himself for re-appointment
    Against Angel One Mutual Fund, Bandhan Mutual Fund, Groww Mutual Fund, LIC Mutual Fund, Motilal Oswal Mutual Fund
    • Angel One Mutual Fund, LIC Mutual FundGovernance concern: Holding combined position of Chairman and Managing Director. Skewed remuneration in favor of promoter directors.
    • Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Governance concern: Holding combined position of Chairman and Managing Director. Skewed remuneration in favor of promoter directors.
    15 for5 against
  • Ratification of remuneration of Cost Auditors for financial year 2025-26
    20 for0 against
  • Reappointment of Mr. Nareshkumar Ramjibhai Patel (DIN 00906232), as the Managing Director, designated as Executive Chairman & Managing Director and approval of payment of remuneration
    Against Angel One Mutual Fund, Bandhan Mutual Fund, Bank of India Mutual Fund, Groww Mutual Fund, Kotak Mahindra Mutual Fund, LIC Mutual Fund, Mirae Asset Mutual Fund, Motilal Oswal Mutual Fund, Trust Mutual Fund
    • Angel One Mutual Fund, LIC Mutual FundGovernance concern: Holding combined position of Chairman and Managing Director. Skewed remuneration in favor of promoter directors. No absolute cap on variable pay.
    • Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Governance concern: Holding combined position of Chairman and Managing Director. Skewed remuneration in favor of promoter directors. No absolute cap on variable pay.
    • Bank of India Mutual FundNareshkumar Ramjibhai Patel received a remuneration of Rs. 49.2 mn in FY25. We estimate his annual fixed remuneration at Rs. 62.9 mn. We note that he is eligible to receive an annual performance incentive, which is at the discretion of the Board/NRC. In the previous terms, his variable pay was capped at one month’s gross salary. Given that this cap has now been removed and the company’s profits have more than doubled in FY25, we cannot reliably estimate the variable pay. The company must provide clarity regarding the variable component and cap the same in absolute amounts. The company must also disclose performance metrics which will determine the variable pay. We support his reappointment to the board as Chairperson and Managing Director, however, given the open-ended structure of remuneration, we do not support this resolution.
    • Kotak Mahindra Mutual FundNareshkumar Ramjibhai Patel received a remuneration of Rs. 49.2 mn in FY25. We estimate his annual fixed remuneration at Rs. 62.9 mn. We note that he is eligible to receive an annual performance incentive, which is at the discretion of the Board/NRC. The company must provide clarity regarding the variable component and cap the same in absolute amounts. The company must also disclose performance metrics which will determine the variable pay. We support his reappointment to the board as Chairperson and Managing Director, however, given the open-ended structure of remuneration, we do not support this resolution.
    • Mirae Asset Mutual FundAs per advisory recommendation (Passive holding)
    • Trust Mutual FundNote that MD is eligible to receive an annual performance incentive, which is at the discretion of the Board/NRC. In the previous terms, his variable pay was capped at one month’s gross salary. Given that this cap has now been removed and the company’s profits have more than doubled in FY25, we cannot reliably estimate the variable pay. The company must provide clarity regarding the variable component and cap the same in absolute amounts.
    11 for9 against
  • Reappointment of Mr. Chetankumar Chhaganlal Vaghasia (DIN 01375540), as the Whole Time Director of Company and approval of payment of remuneration
    Against Angel One Mutual Fund, Bandhan Mutual Fund, Bank of India Mutual Fund, Groww Mutual Fund, Kotak Mahindra Mutual Fund, LIC Mutual Fund, Mirae Asset Mutual Fund, Motilal Oswal Mutual Fund, Trust Mutual Fund
    • Angel One Mutual Fund, LIC Mutual FundGovernance concern: Skewed remuneration in favor of promoter directors. No absolute cap on variable pay.
    • Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Governance concern: Skewed remuneration in favor of promoter directors. No absolute cap on variable pay.
    • Bank of India Mutual FundChetankumar Chhaganlal Vaghasia, 50, is the promoter and Whole time Director. He has around 22 years of experience in the Speciality chemicals manufacturing sector. Currently, he heads the Human Resource, Logistics & Dispatch, Purchase and IT functions of Company and is also involved in the operations, business planning & strategy development of Company. He has served on the board since 12 June 2007 and attended nine out of ten board meetings in FY25 (90%). He received a remuneration of Rs. 48.5 mn in FY25. We estimate his annual fixed remuneration at Rs. 61.6 mn. We note that he is eligible to receive an annual performance incentive, which is at the discretion of the Board/NRC. In the previous terms, his variable pay was capped at one month’s gross salary. Given that this cap has now been removed and the company’s profits have more than doubled in FY25, we cannot reliably estimate the variable pay. The company must provide clarity regarding the variable component and cap the same in absolute amounts. The company must also disclose performance metrics which will determine the variable pay. We support his reappointment to the board as a Whole time Director, however, given the open-ended structure of remuneration, we do not support this resolution.
    • Kotak Mahindra Mutual FundChetankumar Chhaganlal Vaghasia, 50, is the promoter and Whole time Director. He has around 22 years of experience in the Speciality chemicals manufacturing sector. Currently, he heads the Human Resource, Logistics & Dispatch, Purchase and IT functions of Company and is also involved in the operations, business planning & strategy development of Company. He has served on the board since 12 June 2007 and attended nine out of ten board meetings in FY25 (90%). He received a remuneration of Rs. 48.5 mn in FY25. We estimate his annual fixed remuneration at Rs. 61.6 mn. We note that he is eligible to receive an annual performance incentive, which is at the discretion of the Board/NRC. The company must provide clarity regarding the variable component and cap the same in absolute amounts. The company must also disclose performance metrics which will determine the variable pay. We support his reappointment to the board as a Whole time Director, however, given the open-ended structure of remuneration, we do not support this resolution.
    • Mirae Asset Mutual FundAs per advisory recommendation (Passive holding)
    • Trust Mutual FundNote that WTD is eligible to receive an annual performance incentive, which is at the discretion of the Board/NRC. In the previous terms, his variable pay was capped at one month’s gross salary. Given that this cap has now been removed and the company’s profits have more than doubled in FY25, we cannot reliably estimate the variable pay. The company must provide clarity regarding the variable component and cap the same in absolute amounts.
    11 for9 against
  • Reappointment of Mr. Virendra Nath Mishra (DIN 07815490), as the Whole Time Director of Company and approval of payment of remuneration
    Against Bank of India Mutual Fund, Kotak Mahindra Mutual Fund, Mirae Asset Mutual Fund
    • Bank of India Mutual FundVirendra Nath Mishra, 54, is currently Whole time Director and handles the implementation of strategic business decisions like acquisitions, joint ventures, capex, project planning Inventory control, Cost Control and Pilot Plant development. He has over 29 years ex experience in the chemical and pharma industry. He has served on the board since 3 March 2021 and attended all ten board meetings in FY25 (100%). He received a remuneration of Rs. 13.4 mn in FY25. We estimate his annual fixed remuneration at Rs. 21.8 mn. We note that he is eligible to receive an annual performance incentive, which is at the discretion of the Board/NRC. In the previous terms, his variable pay was capped at one month’s gross salary. Given that this cap has now been removed and the company’s profits have more than doubled in FY25, we cannot reliably estimate the variable pay. The company must provide clarity regarding the variable component and cap the same in absolute amounts. Further, he is also eligible to receive ESOPs and the company has not disclosed the proposed quantum of ESOPs that may be granted during this tenure. In the absence of a past trend, we cannot estimate the ESOP component as well. The company must also disclose performance metrics which will determine the variable pay. We support his reappointment to the board as a Whole time Director, however, given the open-ended structure of remuneration, we do not support this resolution.
    • Kotak Mahindra Mutual FundVirendra Nath Mishra, 54, is currently Whole time Director and handles the implementation of strategic business decisions like acquisitions, joint ventures, capex, project planning Inventory control, Cost Control and Pilot Plant development. He has over 29 years ex experience in the chemical and pharma industry. He has served on the board since 3 March 2021 and attended all ten board meetings in FY25 (100%). He received a remuneration of Rs. 13.4 mn in FY25. We estimate his annual fixed remuneration at Rs. 21.8 mn. We note that he is eligible to receive an annual performance incentive, which is at the discretion of the Board/NRC. The company must provide clarity regarding the variable component and cap the same in absolute amounts. Further, he is also eligible to receive ESOPs and the company has not disclosed the proposed quantum of ESOPs that may be granted during this tenure. In the absence of a past trend, we cannot estimate the ESOP component as well. The company must also disclose performance metrics which will determine the variable pay. We support his reappointment to the board as a Whole time Director, however, given the open ended structure of remuneration, we do not support this resolution.
    • Mirae Asset Mutual FundAs per advisory recommendation (Passive holding)
    17 for3 against
  • Re-appointment of Mrs. Richa Manoj Goyal (DIN 00159889), as Director (Non-Executive & Independent) of the company for second term of five years
    20 for0 against
  • Re-appointment of Mr. Hetal Madhukant Gandhi (DIN 00106895), as Director (Non-Executive & Independent) of the company for second term of five years
    Against Angel One Mutual Fund, Bandhan Mutual Fund, Groww Mutual Fund, LIC Mutual Fund, Motilal Oswal Mutual Fund
    • Angel One Mutual FundGovernance concern: Excessive time commitments. Nomination and Remuneration Committee Chairman and Skewed Remuneration in favor of Promoter Executive Directors.
    • Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Governance concern: Excessive time commitments. NRC Chairman and Skewed Remuneration in favor of Promoter EDs.
    • LIC Mutual FundGovernance concern: Excessive time commitments. NRC Chairman and Skewed Remuneration in favor of Promoter EDs.
    15 for5 against
  • Approval for payment of commission to Non - Executive Directors of the Company
    Against Angel One Mutual Fund, Bandhan Mutual Fund, Bank of India Mutual Fund, Groww Mutual Fund, Kotak Mahindra Mutual Fund, LIC Mutual Fund, Mirae Asset Mutual Fund, Motilal Oswal Mutual Fund, Trust Mutual Fund
    • Angel One Mutual FundGovernance concern: Board discretion to distribute the commission. No absolute cap on the proposed commission to Non-Executive Directors and no specific period of approval.
    • Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Governance concern: Board discretion to distribute the commission. No absolute cap on the proposed commission to NEDs and no specific period of approval.
    • Bank of India Mutual FundThe aggregate commission to Non-Executive Directors for FY25 was Rs. 3.5 mn, which stood at 0.16% of standalone PBT. The proposed commission to Non-Executive Directors is in line with market practice. However, the company has not defined a term for the validity of the resolution and thus, it is effectively valid in perpetuity. The company should have also capped such remuneration in absolute terms. We believe shareholders must be able to periodically review such resolutions and, therefore, do not support the resolution.
    • Kotak Mahindra Mutual FundThe aggregate commission to Non-Executive Directors for FY25 was Rs. 3.5 mn, which stood at 0.16% of standalone PBT. The proposed commission to Non-Executive Directors is in line with market practice. However, the company has not defined a term for the validity of the resolution and thus, it is effectively valid in perpetuity. Therefore, we do not support the resolution.
    • LIC Mutual FundGovernance concern: Board discretion to distribute the commission. No absolute cap on the proposed commission to NEDs and no specific period of approval.
    • Mirae Asset Mutual FundAs per advisory recommendation (Passive holding)
    • Trust Mutual FundThe proposed commission to Non-Executive Directors is in line with market practice. However, the company has not defined a term for the validity of the resolution and thus, it is effectively valid in perpetuity. The company should have also capped such remuneration in absolute terms. We believe shareholders must be able to periodically review such resolutions and, therefore, do not support the resolution.
    11 for9 against
  • Appointment of M/s KSPS & Co. LLP as the Secretarial Auditors of Company
    Against Angel One Mutual Fund, Bandhan Mutual Fund, Groww Mutual Fund, LIC Mutual Fund, Motilal Oswal Mutual Fund
    • Angel One Mutual Fund, LIC Mutual FundTransparency concern: The Company neither disclosed the Audit Fee paid to Outgoing Secretarial Auditor nor any material change in the proposed audit fee, if any.
    • Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Transparency concern: The Company neither disclosed the Audit Fee paid to Outgoing Secretarial Auditor nor any material change in the proposed audit fee, if any.
    15 for5 against
6 earlier meetings

Mutual fund votes, meeting of 10 May 2025, 18 fund houses

  • 1) Approve change in name from ‘Ami Organics Limited’ to ‘Acutaas Chemicals Limited’ and consequent amendment to the Memorandum of Association (MoA) and the Articles of Association (AoA).
    1 for0 against
  • 1. To Change the Name of the Company from Ami Organics Limited to Acutaas Chemicals Limited and consequent alteration in the Memorandum of Association and Articles of Association of the Company.
    1 for0 against
  • Approve change in name from ‘Ami Organics Limited’ to ‘Acutaas Chemicals Limited’ and consequent amendment to the Memorandum of Association (MoA) and the Articles of Association (AoA)
    2 for0 against
  • To Change the Name of the Company from Ami Organics Limited to Acutaas Chemicals Limited and consequent alteration in the Memorandum of Association and Articles of Association of the Company.
    14 for0 against

Mutual fund votes, meeting of 26 Mar 2025, 17 fund houses

  • 1) Approve sub-division of equity shares from one equity share of face value of Rs. 10.0 to two equity shares of face value of Rs. 5.0.
    1 for0 against
  • 1. Sub- division/ split of 1 (One) Equity Share of the Company of the face value of Rs. 10/- each fully paid up, into 2 (Two) Equity Shares of the Company of face value of Rs. 5/- each fully paid up.
    1 for0 against
  • 2. Approval for alteration of capital clause (Clause V) of the Memorandum of Association of the Company.
    1 for0 against
  • 2) Approve alteration to the Capital Clause of Memorandum of Association (MoA) to accommodate the sub-division of equity shares.
    1 for0 against
  • Approval for alteration of capital clause (Clause V) of the Memorandum of Association of the Company.
    14 for0 against
  • Approve alteration to the Capital Clause of Memorandum of Association (MoA) to accommodate the sub-division of equity shares
    1 for0 against
  • Approve sub-division of equity shares from one equity share of face value of Rs. 10.0 to two equity shares of face value of Rs. 5.0
    1 for0 against
  • Sub- division/ split of 1 (One) Equity Share of the Company of the face value of Rs. 10/- each fully paid up, into 2 (Two) Equity Shares of the Company of face value of Rs. 5/- each fully paid up.
    14 for0 against

Mutual fund votes, meeting of 20 Sep 2024, 12 fund houses

  • 1) A) Adoption of Audited Standalone Financial Statements for the year ended March 31, 2024 and the reports of the Directors and Auditors thereon. B) Adoption of Audited Consolidated Financial Statements for the year ended March 31, 2024 and Auditors report thereon.MoreLess
    1 for0 against
  • 2) Approve final dividend of Rs. 3.0 per equity share of face value of Rs. 10.0 per share for FY24.
    1 for0 against
  • 3) Reappoint Ram Mohan Lokhande (DIN: 08117035) as Director, liable to retire by rotation.
    1 for0 against
  • 4) Approve remuneration of Rs. 300,000 payable to Chirag Vallabhbhai Vekariya & Co. as cost auditors for FY25.
    1 for0 against
  • 5) Approve payment of remuneration to Ram Mohan Lokhande (DIN: 08117035) as Whole time Director from 8 February 2025 till the completion of his tenure on 7 February 2027.
    1 for0 against
  • Declaration of Final Dividend at the rate of 30% i. e Rs. 3/- per equity share of the face value of Rs. 10/- each, on 4,09,27,511 equity shares of the company for the financial year 2023 - 24.
    11 for0 against
  • Payment of remuneration, to Mr. Ram Mohan Lokhande (DIN: 08117035) Whole Time Director of the Company (appointed by the shareholders of the Company on April 28, 2022 for a tenure of 5 years w. e .f February 8, 2022 and approval of remuneration under Schedule V for a period of three years w. e. f February 8, 2022 till February 7, 2025) during the remaining period of his present tenure i. e from February 8, 2025 till February 7, 2027, and that such remuneration shall not exceed 5% (five percent) per annum of the net profits of Company.MoreLess
    Against Bank of India Mutual Fund
    • Bank of India Mutual FundRam Mohan Lokhande, 46, is the Whole time Director designated as Chief Risk Officer. He has over 22 years of experience in pharma and chemical industries. He has been on the board since 8 February 2022. He has attended all eight board meetings in FY24 (100%). He was appointed as a Whole time Director w.e.f. 8 February 2022 for five years while his remuneration was approved for three years. The company now proposes to take shareholder approval for his remuneration for the remainder of his term. He was paid a remuneration of Rs. 13.0 mn in FY24. As per his current terms, we cannot reliably estimate his annual remuneration. The company has not disclosed the proposed ESOP grants to him during his tenure. The past grants were a one-time grant from a smaller pool, while the size of future grants may be significantly higher, given that another scheme was approved by shareholders in FY24. While we recognize that his fixed and annual variable performance bonus components are capped, his ESOP component is open-ended and as a consequence his entire remuneration structure is open-ended. We expect the company to disclose the stock options proposed to be granted to him during his tenure and also disclose performance metrics which will determine his variable pay. We do not support this resolution.
    10 for1 against
  • Ratification of remuneration of Rs. 3,00,000/- excluding out of pocket expenses plus applicable taxes payable to M/s Chirag Vallabhbhai Vekariya and Co., Cost and Management Accountants (Firm’s Registration No. 001422) who have been appointed by the Board of Directors as the Cost Auditors of the Company, to conduct the cost audit of the cost records of Company for the F.Y. 2024 - 25.MoreLess
    11 for0 against
  • Re-appointment of Mr. Ram Mohan Lokhande (DIN: 08117035), who retires by rotation and being eligible, offers himself for re-appointment.
    11 for0 against
  • To consider approve and adopt: a) The audited Standalone Financial Statements including Balance Sheet as at March 31, 2024 and Profit and Loss Account and Cash Flow Statement for the year ended on that date together with the schedules and notes attached thereto along with the Reports of Board of Directors and the Auditors thereon b) The audited Consolidated Financial Statements including Balance Sheet as at March 31, 2024 and Profit and Loss Account and Cash Flow Statement for the year ended on that date together with the schedules and notes attached thereto, along with the Reports of Board of Directors and the Auditors thereon.MoreLess
    11 for0 against

Mutual fund votes, meeting of 19 Sep 2024, 1 fund house

  • 1. Adoption of the Audited Financial Statements of the Company together with the schedules and notes attached thereto for the financial year ended on 31st March, 2024 along with the reports of the Board of Directors and Auditors thereon 2. Declaration of Final Dividend for the financial year 2023-24 3. Re-appointment of Mr. Ram Mohan Lokhande, who retires by rotation and being eligible, offers himself for re-appointment 4. Ratification of remuneration of Cost Auditors for financial year 2024-25 5. Approval of payment of remuneration to Mr. Ram Mohan Lokhande (DIN: 08117035), Whole Time DirectorMoreLess
    1 for0 against

Mutual fund votes, meeting of 27 May 2024, 8 fund houses

  • To approve,create,offer,issue and allot upto 7,99,193 equity shares of the company on preferential basis.
    1 for0 against
  • To create, issue, offer and allot, from time to time and in one or more tranches on a preferential basis, up to 7,99,193 Equity Shares of face value of Rs. 10/- each for cash, at an issue price of Rs. 1,240/- per Equity Share including premium of Rs. 1,230/- per Equity Share, in accordance with the provisions of Chapter V of SEBI ICDR Regulations (Subscription Shares), for an aggregate amount of up to Rs. 99,09,99,320 to the below mentioned proposed allottees ( Proposed Allottees ) for cash consideration by way of preferential issue on a private placement basis (Preferential Issue).MoreLess
    7 for0 against

Mutual fund votes, meeting of 14 May 2024, 7 fund houses

  • To borrow from time to time all such sums of money as the Board of Directors of the Company (hereinafter referred to as the Board, which term shall include any Committee constituted by the Board or any person(s) authorized by the Board to exercise the powers conferred on the Board by this Resolution), may deem requisite for the purpose of the business (including but not limited to, for financing any capital or revenue requirements, new business ventures or prospects or other financial needs) of the Company and/or its subsidiary(ies), notwithstanding that moneys to be borrowed together with moneys already borrowed by the Company (apart from temporary loans obtained from the Company’s Bankers in the ordinary course of business) may exceed the aggregate of the paid-up share capital of the Company, free reserves that is to say, reserves not set apart for any specific purposes and securities premium amount of the Company, provided, however, that the total amount so borrowed including fund /non fund based borrowings (other than temporary loans from the Company’s bankers in the ordinary course of business) outstanding at any point of time shall not exceed a sum of Rs. 5000 million.MoreLess
    Against Groww Mutual Fund, Motilal Oswal Mutual Fund
    • Groww Mutual FundCompliant with law. Governance Concern: Majority of the borrowing limit is unutilized and absence of specific reasons for the proposed increase.
    • Motilal Oswal Mutual Fund"Majority of the borrowing limits is Unutilized and absence of specific reasons for the proposed increase. "
    5 for2 against
  • To create mortgage, charge and/or hypothecation in addition to the existing mortgages, charges and hypothecation created by the Company as may be necessary on such of the assets of the Company, both present and future, in such manner as the Board may direct, together with granting the power to take over the management of the Company in certain events, to or in favour of financial institutions, non-banking finance companies, co-operative banks, investment institutions and their subsidiaries, banks, mutual funds, trusts and other bodies corporate (hereinafter referred to as the Lending Agencies) or trustees for the holders of debentures/ bonds and/ or other instruments or otherwise, to secure rupee term loans/ foreign currency loans, debentures, bonds and other instruments of an equivalent aggregate value outstanding at any point of time not exceeding Rs. 5000 million.MoreLess
    Against Groww Mutual Fund, Motilal Oswal Mutual Fund
    • Groww Mutual FundCompliant with law. Governance Concern: Majority of the borrowing limit is unutilized and absence of specific reasons for the proposed increase.
    • Motilal Oswal Mutual Fund"Interlinked to resolution #2 Approval for increase in Borrowing Powers of the Company"
    5 for2 against
  • To create, offer, issue and allot with or without green shoe option, such number of Equity Shares, and / or other securities convertible into Equity Shares, fully convertible debentures, with or without warrants and/ or convertible preference shares or any security convertible into Equity Shares (hereinafter referred to as Securities), or any combination thereof, in one or more tranches, in Rupee denomination, in the course of domestic offerings, in terms of the applicable regulations and as permitted under the applicable laws, in such manner and in consultation with the lead manager(s) / book running lead manager(s) and/or other advisor(s) or otherwise, for an aggregate amount not exceeding Rs. 5000 million.MoreLess
    Against Groww Mutual Fund, Motilal Oswal Mutual Fund
    • Groww Mutual FundCompliant with Law. Governance concern: Excessive dilution. No specific justification which indicates urgent need of funds.
    • Motilal Oswal Mutual Fund"Excessive dilution and no specific justification for urgent need of funds"
    5 for2 against

Each fund house counted once, from its own disclosure; the reasons are its own words.

Tax disputes

Reported in the filing for the quarter to Jun 2026.

  • Tax disputeNew India Assurance Company LimitedSince 26 Apr 2024
    As on June 30, 2026 the final hearing /examination of parties is pending by Honorable Sole Arbitrator.
    At the filing before: Company had sought initiation of arbitration proceeding and appointment of Arbitrator under the Industrial All Risk Insurance Policy in respect of shortfall in receipt of claim of Rs. 4.31 crores, by its application to the Hon'ble High Court of Bombay, which was accepted and Arbitrator had been appointed by the Hon'ble High Court of Bombay vide its order updated on April 26, 2024 to decide on the dispute between the Parties.MoreLess
  • Tax disputeCommissioner of Income Tax (Appeals)Since 11 Jan 2025
    Appeal is filed before Commissioner of Income Tax (Appeals) and hearing is awaited.
    At the filing before: Company received an Assessment Order dated December 12, 2024, under section 143(3) of Income-tax Act, 1961, for the income tax return filed for the financial year 2021-22, wherein certain additions/ disallowances with respect to returned income, have been proposed by the assessing officer for principal tax liability amounting to approximately Rs. 10.20 crores excluding the relevant interest and penalties, if any, as stipulated under the Income Tax Act, 1961.MoreLess

In the company's own words, from its latest governance filing.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

  • Received
  • Resolved

Open at the quarter's end

At most 2 complaints open, quarter to Dec 2025.
The board is made up as the listing rules require
Yes
The board has a regular chairperson
Yes
The company has a risk management committee
Yes
The chair is related to the managing director
Yes
The filing has a part on fines and penalties
No
The filing has a part on tax disputes
Yes
There was a cyber security incident in the quarter
No

The company's own answers in its filing.

How money raised was used

Reported for the quarter to Jun 2025. The company's results filing for the quarter to Jun 2026 says no statement of how money raised was used applies to it. A preferential issue sells new shares to chosen investors rather than to the public. A warrant or partly paid issue plans the whole issue while the money comes in over time, so the amount set aside can be more than raised so far.

RaisedAmount raisedForSet asideSpentSpent elsewhere
Preferential IssuesMay 202499.10Capital Expenditure required for electrolytes additives and /or allied business of the Company and/or its subsidiaries77.0077.00No
Preferential IssuesMay 202499.10GENERAL CORPORATE PURPOSE22.1022.10No
₹ crore. Checked by is the agency appointed to monitor how the money is used. The reason and the comments are the company's, its audit committee's and its auditors' own words.